{"id": "236950", "url": "https://fevir.net/resources/EvidenceVariable/236950", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"], "versionId": "73", "lastUpdated": "2025-10-07T17:12:54.639Z"}, "title": "GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA", "author": [{"name": "Computable Publishing\u00ae: MAGIC-to-FEvIR Converter"}], "citeAs": "GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing\u00ae: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236950. Revised 2025-10-07. Available at: https://fevir.net/resources/EvidenceVariable/236950. Computable resource at: https://fevir.net/resources/EvidenceVariable/236950#json.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "category": [{"name": "SGLT2 inhibitors", "valueReference": {"type": "Group", "display": "Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors", "reference": "Group/236769", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-intervention-85394-I-85798", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}}, {"name": "GLP-1 RA", "valueReference": {"type": "Group", "display": "Glucagon-Like Peptide-1 (GLP-1) receptor agonists", "reference": "Group/236776", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-comparator-85394-C-85798", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "publisher": "Computable Publishing LLC", "relatesTo": [{"type": "part-of", "targetReference": {"type": "Composition", "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-conversion-report", "assigner": {"display": "Computable Publishing LLC"}}}}], "definition": {"concept": {"coding": [{"code": "defined-in-handling-and-category", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Defined in handling and category elements"}]}}, "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "236950", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-group-assignment-85394-85798", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "EvidenceVariable", "name": "GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA", "handling": "dichotomous", "description": "This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide."}